126 related articles for article (PubMed ID: 11575041)
1. Recent discoveries in assessment of coronary heart disease: impact of vascular mechanisms on development of atherosclerosis.
Chilton RJ
J Am Osteopath Assoc; 2001 Sep; 101(9 Suppl):S1-5. PubMed ID: 11575041
[TBL] [Abstract][Full Text] [Related]
2. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
3. Identifying the vulnerable patient with rupture-prone plaque.
Weintraub HS
Am J Cardiol; 2008 Jun; 101(12A):3F-10F. PubMed ID: 18549869
[TBL] [Abstract][Full Text] [Related]
4. Lipid oxidation and atherosclerosis.
Nilsson J; Regnström J; Frostegård J; Stiko A
Herz; 1992 Oct; 17(5):263-9. PubMed ID: 1473812
[TBL] [Abstract][Full Text] [Related]
5. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
6. [Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease].
Galle J
Herz; 2004 Feb; 29(1):4-11. PubMed ID: 14968336
[TBL] [Abstract][Full Text] [Related]
7. Does reversal of oxidative stress and inflammation provide vascular protection?
Koh KK; Oh PC; Quon MJ
Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
[TBL] [Abstract][Full Text] [Related]
8. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions.
Mason RP; Walter MF; Day CA; Jacob RF
Am J Cardiol; 2005 Sep; 96(5A):11F-23F. PubMed ID: 16126019
[TBL] [Abstract][Full Text] [Related]
9. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes].
Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B
Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071
[TBL] [Abstract][Full Text] [Related]
10. Lipid lowering therapy in atherosclerosis.
Aikawa M; Libby P
Semin Vasc Med; 2004 Nov; 4(4):357-66. PubMed ID: 15861316
[TBL] [Abstract][Full Text] [Related]
11. Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction.
Ito MK; Talbert RL; Tsimikas S
Pharmacotherapy; 2006 Jul; 26(7 Pt 2):85S-97S; discussion 98S-101S; quiz 106S-108S. PubMed ID: 16803418
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of plaque instability.
Shah PK
Curr Opin Lipidol; 2007 Oct; 18(5):492-9. PubMed ID: 17885418
[TBL] [Abstract][Full Text] [Related]
13. Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy.
Tamargo J; Caballero R; Gómez R; Núñez L; Vaquero M; Delpón E
Pharmacol Ther; 2007 Apr; 114(1):107-26. PubMed ID: 17287023
[TBL] [Abstract][Full Text] [Related]
14. Role of platelets in the pathophysiology of acute coronary syndrome.
Massberg S; Schulz C; Gawaz M
Semin Vasc Med; 2003 May; 3(2):147-62. PubMed ID: 15199478
[TBL] [Abstract][Full Text] [Related]
15. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin system antagonism and lipid-lowering therapy in cardiovascular risk management.
Chiong JR; Miller AB
J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):96-102. PubMed ID: 12228849
[TBL] [Abstract][Full Text] [Related]
17. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
18. Low-density lipoprotein cholesterol determines oxidative stress and endothelial dysfunction in saphenous veins from patients with coronary artery disease.
Al-Benna S; Hamilton CA; McClure JD; Rogers PN; Berg GA; Ford I; Delles C; Dominiczak AF
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):218-23. PubMed ID: 16254199
[TBL] [Abstract][Full Text] [Related]
19. Role of oxidative modifications in atherosclerosis.
Stocker R; Keaney JF
Physiol Rev; 2004 Oct; 84(4):1381-478. PubMed ID: 15383655
[TBL] [Abstract][Full Text] [Related]
20. Risk stratification of individual coronary lesions using local endothelial shear stress: a new paradigm for managing coronary artery disease.
Chatzizisis YS; Coskun AU; Jonas M; Edelman ER; Stone PH; Feldman CL
Curr Opin Cardiol; 2007 Nov; 22(6):552-64. PubMed ID: 17921744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
